These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19394230)

  • 1. 6-amino-4-oxo-1,3-diphenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonyl derivatives as a new class of potent inhibitors of Interleukin-8-induced neutrophil chemotaxis.
    Cesarini S; Spallarossa A; Ranise A; Bruno O; Arduino N; Bertolotto M; Dallegri F; Tognolini M; Gobbetti T; Barocelli E
    Bioorg Med Chem; 2009 May; 17(10):3580-7. PubMed ID: 19394230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors.
    Bruno O; Brullo C; Bondavalli F; Schenone S; Spisani S; Falzarano MS; Varani K; Barocelli E; Ballabeni V; Giorgio C; Tognolini M
    Bioorg Med Chem; 2009 May; 17(9):3379-87. PubMed ID: 19362486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of N-pyrazolyl-N'-alkyl/benzyl/phenylureas: a new class of potent inhibitors of interleukin 8-induced neutrophil chemotaxis.
    Bruno O; Brullo C; Bondavalli F; Schenone S; Ranise A; Arduino N; Bertolotto MB; Montecucco F; Ottonello L; Dallegri F; Tognolini M; Ballabeni V; Bertoni S; Barocelli E
    J Med Chem; 2007 Jul; 50(15):3618-26. PubMed ID: 17608466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.
    Moriconi A; Cesta MC; Cervellera MN; Aramini A; Coniglio S; Colagioia S; Beccari AR; Bizzarri C; Cavicchia MR; Locati M; Galliera E; Di Benedetto P; Vigilante P; Bertini R; Allegretti M
    J Med Chem; 2007 Aug; 50(17):3984-4002. PubMed ID: 17665889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic hexa- and heptapeptides that inhibit IL-8 from binding to and activating human blood neutrophils.
    Hayashi S; Kurdowska A; Miller EJ; Albright ME; Girten BE; Cohen AB
    J Immunol; 1995 Jan; 154(2):814-24. PubMed ID: 7814885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
    Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism.
    Rot A
    Eur J Immunol; 1993 Jan; 23(1):303-6. PubMed ID: 8419183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human neutrophil chemotaxis toward interleukin 8 with six clinical antithrombin concentrates in vitro.
    Kaneider NC; Rabensteiner A; Reinisch CM; Dunzendorfer S; Wiedermann CJ
    Intensive Care Med; 2002 Oct; 28(10):1447-52. PubMed ID: 12373470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
    de Haas CJ; Veldkamp KE; Peschel A; Weerkamp F; Van Wamel WJ; Heezius EC; Poppelier MJ; Van Kessel KP; van Strijp JA
    J Exp Med; 2004 Mar; 199(5):687-95. PubMed ID: 14993252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.
    Zhang YM; Fan X; Xiang B; Chakravarty D; Scannevin R; Burke S; Karnachi P; Rhodes K; Jackson P
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3096-100. PubMed ID: 16632358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological activity of 1,3,6-trisubstituted-4-oxo-1,4-dihydroquinoline-2-carboxylic acids as selective ET(A) antagonists.
    Patel HJ; Olgun N; Lengyel I; Reznik S; Stephani RA
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6840-4. PubMed ID: 20932745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.
    Kubota K; Kurebayashi H; Miyachi H; Tobe M; Onishi M; Isobe Y
    Bioorg Med Chem; 2011 May; 19(9):3005-21. PubMed ID: 21470866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives as highly potent and specific COX-2 inhibitors.
    Orjales A; Mosquera R; López B; Olivera R; Labeaga L; Núñez MT
    Bioorg Med Chem; 2008 Mar; 16(5):2183-99. PubMed ID: 18158247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of morphine sulfate on neonatal neutrophil chemotaxis.
    Yossuck P; Nightengale BJ; Fortney JE; Gibson LF
    Clin J Pain; 2008 Jan; 24(1):76-82. PubMed ID: 18180640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor.
    Winters MP; Crysler C; Subasinghe N; Ryan D; Leong L; Zhao S; Donatelli R; Yurkow E; Mazzulla M; Boczon L; Manthey CL; Molloy C; Raymond H; Murray L; McAlonan L; Tomczuk B
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1926-30. PubMed ID: 18308567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Anti-HIV-1 Evaluation of a Novel Series of 1,2,3,4-Tetrahydropyrimidine-5-Carboxylic Acid Derivatives.
    Sepehri S; Soleymani S; Zabihollahi R; Aghasadeghi MR; Sadat M; Saghaie L; Memarian HR; Fassihi A
    Chem Biodivers; 2018 Apr; 15(4):e1700502. PubMed ID: 29411517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis.
    Bruno O; Brullo C; Bondavalli F; Ranise A; Schenone S; Falzarano MS; Varani K; Spisani S
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3696-701. PubMed ID: 17475488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonists.
    Liu S; Liu Y; Wang H; Ding Y; Wu H; Dong J; Wong A; Chen SH; Li G; Chan M; Sawyer N; Gervais FG; Henault M; Kargman S; Bedard LL; Han Y; Friesen R; Lobell RB; Stout DM
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5741-5. PubMed ID: 19713110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2-sulfanyl-6-methyl-1,4-dihydropyrimidines as a new class of antifilarial agents.
    Singh BK; Mishra M; Saxena N; Yadav GP; Maulik PR; Sahoo MK; Gaur RL; Murthy PK; Tripathi RP
    Eur J Med Chem; 2008 Dec; 43(12):2717-23. PubMed ID: 18339456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists.
    Biju P; Taveras A; Yu Y; Zheng J; Chao J; Rindgen D; Jakway J; Hipkin RW; Fossetta J; Fan X; Fine J; Qiu H; Merritt JR; Baldwin JJ
    Bioorg Med Chem Lett; 2008 Jan; 18(1):228-31. PubMed ID: 18006311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.